Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001, 61: 2537-2541.
CAS
PubMed
Google Scholar
Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyers R, Grohe C: Estrogen receptor-alpha rapidly activates the IGF-I receptor pathway. J Biol Chem. 2000, 275: 18447-18453. 10.1074/jbc.M910345199.
Article
CAS
PubMed
Google Scholar
Razandi M, Pedram A, Levin ER: Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol. 2000, 14: 1434-1447. 10.1210/me.14.9.1434.
Article
CAS
PubMed
Google Scholar
Peitras RJ, Szego CM: Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 1977, 265: 69-72.
Article
Google Scholar
Buzdar AU: Endocrine therapy in the treatment of metastatic breast cancer. Semin Oncol. 2001, 28: 291-304. 10.1053/sonc.2001.23495.
Article
CAS
PubMed
Google Scholar
Jiang S-Y, Jordan VC: Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst. 1992, 84: 580-591.
Article
CAS
PubMed
Google Scholar
Garcia M, Derocq D, Freiss G, Rochefort H: Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic potential and invasive potential of the cells. Proc Natl Acad Sci USA. 1992, 89: 11538-11542.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zajchowski DA, Sager R, Webster L: Estrogen inhibits growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant receptor. Cancer Res. 1993, 53: 5004-5011.
CAS
PubMed
Google Scholar
Lundholt BK, Madsen MW, Lykkesfeldt AE, Petersen OW, Briand P: Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA. Mol Cell Endocrinol. 1996, 119: 47-59. 10.1016/0303-7207(96)03793-8.
Article
CAS
PubMed
Google Scholar
Lazennec G, Katzenellenbogen BS: Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol. 1999, 149: 93-105. 10.1016/S0303-7207(98)00254-8.
Article
CAS
PubMed
Google Scholar
Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV: Re-expression of estrogen receptor-α in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res. 2001, 61: 5771-5777.
CAS
PubMed
Google Scholar
Yee D, Lee AV: Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia. 2000, 5: 107-115. 10.1023/A:1009575518338.
Article
CAS
PubMed
Google Scholar
Stewart AJ, Westley BR, May FE: Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer. 1992, 66: 640-648.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D: Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol. 1999, 13: 787-796. 10.1210/me.13.5.787.
Article
CAS
PubMed
Google Scholar
Miller DL, El-Ashry D, Cheville AL, Liu Y, McLeskey SW, Kern FG: Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ. 1994, 5: 1263-1274.
CAS
PubMed
Google Scholar
Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D: Hyperactivation of MAPK induces loss of ER-alpha expression in breast cancer cells. Mol Endocrinol. 2001, 15: 1344-1359. 10.1210/me.15.8.1344.
CAS
PubMed
Google Scholar
Zhuang Y, Katzenellenbogen BS, Shapiro DJ: Estrogen receptor mutants which do not bind 17beta-estradiol dimerize and bind to estrogen response element in vivo. Mol Endocrinol. 1995, 9: 457-466. 10.1210/me.9.4.457.
CAS
PubMed
Google Scholar
Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F: ER-beta inhibits proliferation and invasion of breast cancer cells. Endocrinology. 2001, 142: 4120-4130. 10.1210/en.142.9.4120.
CAS
PubMed
PubMed Central
Google Scholar
Soto AM, Sonnenshcein C: The two faces of Janus: sex steroids as mediators of both cell proliferation and cell death. J Natl Cancer Inst. 2001, 93: 1673-1675. 10.1093/jnci/93.22.1673.
Article
CAS
PubMed
Google Scholar